Skip to main content
S 178 108th Congress Senate Health Coinsurance Employee health benefits Finance and Financial Sector Health insurance Hospital care Immunosuppressive drugs Insurance premiums Kidney diseases Labor and Employment Medicare Social Welfare Transplantation of organs, tissues, etc.

Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003

Introduced: January 16, 2003 Introduced by: Durbin, Richard J. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 16, 2003
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1071-1072)
Jan 16, 2003
Sponsor introductory remarks on measure. (CR S1071)
Jan 16, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, to remove time limitations on the coverage of immunosuppressive drugs for individuals who have received organ transplants. (Current law provides coverage for such drugs only for certain time periods after the transplant procedure.)

Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney or other organ transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease beneficiaries.

Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs.

What's happening now January 16, 2003

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1071-1072)

 Related & companion bills 1
  • HR 2223 Identical bill Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Murray, Patty
Washington · Jun 18, 2004
Cite this page click to expand
APA
U.S. Congress. (2026). S. 178: Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-S-178/
MLA
"S. 178: Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-178/.
Bluebook (legal)
S. 178, 108th Cong. (2026), https://openamerica.io/bill/108-S-178/.
Markdown link
[S. 178: Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003](https://openamerica.io/bill/108-S-178/)
Report a problem